Free Trial

Orthofix Medical (OFIX) Insider Trading & Ownership

Orthofix Medical logo
$18.91 +0.23 (+1.23%)
(As of 11/22/2024 ET)

Orthofix Medical (NASDAQ:OFIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.60%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$101,025.00
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$232,267.50
Get OFIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orthofix Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OFIX Insider Buying and Selling by Quarter

Orthofix Medical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2023James F HinrichsDirectorBuy7,500$13.47$101,025.00  
5/26/2023Kevin J KennyInsiderSell3,876$19.00$73,644.00  
5/24/2023Kevin J KennyInsiderSell4,367$19.00$82,973.00  
3/10/2023Shweta ManiarDirectorSell4,262$17.75$75,650.50  
(Data available from 1/1/2013 forward)

OFIX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Orthofix Medical includes James F Hinrichs, Kevin J Kenny, and Shweta Maniar. Learn more on insiders at OFIX.

2.60% of Orthofix Medical stock is owned by insiders. Learn more on OFIX's insider holdings.

The following insider purchased OFIX shares in the last 24 months: James F Hinrichs ($101,025.00).

Insiders have purchased a total of 7,500 OFIX shares in the last 24 months for a total of $101,025.00 bought.

The following insiders have sold OFIX shares in the last 24 months: Kevin J Kenny ($156,617.00), and Shweta Maniar ($75,650.50).

Insiders have sold a total of 12,505 Orthofix Medical shares in the last 24 months for a total of $232,267.50 sold.

Orthofix Medical Key Executives

  • Mr. Geoffrey C. Gillespie
    VP & Corporate Controller
  • Mr. Massimo Calafiore (Age 52)
    President, CEO, Director and Interim President of Global Spine
  • Ms. Julie B. Andrews (Age 53)
    Chief Financial Officer
  • Ms. Aviva McPherron
    President of Global Operations & Quality
  • Ms. Julie D. Dewey (Age 63)
    Chief Investor Relations & Communications Officer
  • Ms. Jill Mason
    Interim Chief Ethics & Compliance Officer and VP of Corporate Counsel
  • Mr. J. Andres Cedron (Age 43)
    Chief Legal Officer & Corporate Secretary
  • Ms. Stephanie Walsh
    Chief Human Resources Officer
  • Mr. Ehab M. Esmail (Age 52)
    Senior Vice President of Global Quality, Regulatory & Clinical Affairs
  • Mr. Tyler P. Lipschultz (Age 57)
    President of Global Biologics


This page (NASDAQ:OFIX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners